Kinetic studies of dopamine D2 receptor molecular pharmacology
The dopamine D2 receptor (D2R) is a G protein-coupled receptor (GPCR) that is the primary target of drugs treating the symptoms of Parkinson’s disease and schizophrenia. However, drugs acting at the D2R to manage these diseases often display efficacy for only a subset of their symptoms and have poor...
| Main Author: | Keen, Alastair C. |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2021
|
| Online Access: | https://eprints.nottingham.ac.uk/64380/ |
Similar Items
Medicinal Chemistry & Chemical Biology Approaches to Investigate Prospective Treatments for CNS Diseases: Dopamine D1 Receptor Positive Allosteric Modulators, Dopamine D2 Receptor Positive & Negative Allosteric Modulators, Dopamine D2 Receptor-Ligand Kinetics
by: Fyfe, Tim
Published: (2019)
by: Fyfe, Tim
Published: (2019)
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
by: Sykes, David A., et al.
Published: (2017)
by: Sykes, David A., et al.
Published: (2017)
Determination of agonist intrinsic efficacies at the dopamine D2 receptor
by: Stott, Lisa Alice
Published: (2017)
by: Stott, Lisa Alice
Published: (2017)
D-amphetamine and antipsychotic drug effects on latent
inhibition in mice lacking dopamine D2 receptors
by: Bay-Richter, C., et al.
Published: (2013)
by: Bay-Richter, C., et al.
Published: (2013)
Dopamine D1 receptor involvement in latent inhibition and overshadowing
by: Nelson, Andrew J.D., et al.
Published: (2012)
by: Nelson, Andrew J.D., et al.
Published: (2012)
The dopamine D3-preferring D2/D3 dopamine receptor partial agonist, cariprazine, reverses behavioral changes in a rat neurodevelopmental model for schizophrenia
by: Watson, David J.G., et al.
Published: (2016)
by: Watson, David J.G., et al.
Published: (2016)
Controlled dopamine (D1) receptor stimulation using photo-responsive substrates
by: Rajput, Sunil
Published: (2019)
by: Rajput, Sunil
Published: (2019)
A thieno[2,3-d]pyrimidine scaffold is a novel negative allosteric modulator of the dopamine D2 receptor
by: Fyfe, Tim J., et al.
Published: (2018)
by: Fyfe, Tim J., et al.
Published: (2018)
The role of dopamine D2 and neuregulin-1 receptors in schizophrenia relevant phenotypes of cognition, attention and memory
by: Mathur, Naina
Published: (2012)
by: Mathur, Naina
Published: (2012)
Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia
by: Lawford, B., et al.
Published: (2016)
by: Lawford, B., et al.
Published: (2016)
On-Demand Dopamine Receptor Activation via Photoresponsive Nanoparticle-Dopamine Conjugates with an Emphasis on Parkinson’s Disease
by: Alghamdi, Hajar
Published: (2024)
by: Alghamdi, Hajar
Published: (2024)
Dopamine D1-like receptor signalling in the hippocampus and amygdala modulates the acquisition of contextual fear conditioning
by: Heath, Florence C., et al.
Published: (2015)
by: Heath, Florence C., et al.
Published: (2015)
Corticosterone and dopamine D2/D3 receptors mediate the
motivation for voluntary wheel running in C57BL/6J mice
by: Ebada, Mohamed Elsaed Elsayed, et al.
Published: (2016)
by: Ebada, Mohamed Elsaed Elsayed, et al.
Published: (2016)
No Association of Polymorphisms in the Dopamine Receptor D2 (DRD2) Gene with Cold Pressor Pain Sensitivity among Healthy Malay Males
Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand
by: Mistry, Shailesh N., et al.
Published: (2015)
by: Mistry, Shailesh N., et al.
Published: (2015)
Detection of Dopamine receptors (D1-like and D2-like) mRNA expression in peripheral blood lymphocytes of healthy Malay men subjects.
Dopamine D1 receptor stimulation modulates the formation and retrieval of novel object recognition memory: role of the prelimbic cortex
by: Pezze, Marie A., et al.
Published: (2015)
by: Pezze, Marie A., et al.
Published: (2015)
Perinatal maternal alcohol consumption and methylation of the dopamine receptor DRD4 in the offspring: the Triple B study
by: Fransquet, P., et al.
Published: (2016)
by: Fransquet, P., et al.
Published: (2016)
Reduced Dopamine D4 Receptor mRNA expression in lymphocytes among Malay Men undergoing methadone maintenance treatment.
Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase
by: Wana, Mohammed Nasiru, et al.
Published: (2023)
by: Wana, Mohammed Nasiru, et al.
Published: (2023)
Genetic analysis of beta 2 adrenergic and Dopamine receptor gene polymorphisms in hypertensive subjects at Hospital Seremban, Malaysia
by: Komara, Makanko
Published: (2013)
by: Komara, Makanko
Published: (2013)
An evaluation of DREADD receptor pharmacology in recombinant cells and astrocytes
by: Carpenter, Jessica
Published: (2020)
by: Carpenter, Jessica
Published: (2020)
Prevalence of Hypertension in University Students and Association of Catechol-O Methyltransferase (Val158met) and Dopamine D2 Receptor (Taq1a) Polymorphism with Hypertension
by: Gan, Kelvin
Published: (2016)
by: Gan, Kelvin
Published: (2016)
Investigations into β2-adrenoceptor pharmacology: kinetic analysis, mechanotransduction and allosteric modulation
by: Cullum, Sean A.
Published: (2024)
by: Cullum, Sean A.
Published: (2024)
Evaluation of the dopamine and serotonin receptor binding activity of selected aporphines / Vani A/P Munusamy
by: Vani, Munusamy
Published: (2012)
by: Vani, Munusamy
Published: (2012)
Molecular modelling of the cannabinoid receptors: structure-based design, synthesis and pharmacological evaluation of novel ligands based on the fenofibrate scaffold
by: Loo, Jason S. E.
Published: (2015)
by: Loo, Jason S. E.
Published: (2015)
Cannabis use by women during pregnancy does not influence infant DNA methylation of the dopamine receptor DRD4
by: Fransquet, P., et al.
Published: (2017)
by: Fransquet, P., et al.
Published: (2017)
Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2
by: Peach, Chloe, et al.
Published: (2018)
by: Peach, Chloe, et al.
Published: (2018)
Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2) deficient mice: Do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?
by: O'Callaghan, M.J., et al.
Published: (2014)
by: O'Callaghan, M.J., et al.
Published: (2014)
Molecular Probes for P2X7 Receptor Studies
by: Gunosewoyo, Hendra, et al.
Published: (2007)
by: Gunosewoyo, Hendra, et al.
Published: (2007)
Pharmacological interactions between phenylbenzothiazoles and aryl hydrocarbon receptor (AhR)
by: Bazzi, Rana
Published: (2008)
by: Bazzi, Rana
Published: (2008)
Pharmacological characterisation of the fatty acid receptors GPR120 and FFA1
by: Watson, Sarah-Jane
Published: (2013)
by: Watson, Sarah-Jane
Published: (2013)
Molecular pharmacological studies of CHFI-FXII interaction and FXII function
by: Kareem Hamad, B.
Published: (2016)
by: Kareem Hamad, B.
Published: (2016)
Design, synthesis and pharmacological evaluation of novel fluorescent ligands for the mu-opioid receptor
by: Marshall, William
Published: (2021)
by: Marshall, William
Published: (2021)
Angiotensin receptor neprilysin inhibitor LCZ696: Pharmacology, pharmacokinetics and clinical development
by: Hua, Y., et al.
Published: (2017)
by: Hua, Y., et al.
Published: (2017)
Pharmacological analysis and structure determination of
7-methylcyanopindolol–bound b1-adrenergic receptor
by: Sato, Tomomi, et al.
Published: (2015)
by: Sato, Tomomi, et al.
Published: (2015)
Dopamine receptors (DRD4 and DRD5) mRNA expression in peripheral blood lymphocytes of healthy Malay men subjects
The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator
by: Brandish, P., et al.
Published: (2014)
by: Brandish, P., et al.
Published: (2014)
Molecular mechanism of DLBS3233 bioactive fraction in type-2 diabetes mellitus: network pharmacology and docking study
by: Tan, Santi, et al.
Published: (2023)
by: Tan, Santi, et al.
Published: (2023)
Effects of dopamine D1 modulation of the anterior cingulate cortex in a fear conditioning procedure
by: Pezze, Marie A., et al.
Published: (2015)
by: Pezze, Marie A., et al.
Published: (2015)
Similar Items
-
Medicinal Chemistry & Chemical Biology Approaches to Investigate Prospective Treatments for CNS Diseases: Dopamine D1 Receptor Positive Allosteric Modulators, Dopamine D2 Receptor Positive & Negative Allosteric Modulators, Dopamine D2 Receptor-Ligand Kinetics
by: Fyfe, Tim
Published: (2019) -
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
by: Sykes, David A., et al.
Published: (2017) -
Determination of agonist intrinsic efficacies at the dopamine D2 receptor
by: Stott, Lisa Alice
Published: (2017) -
D-amphetamine and antipsychotic drug effects on latent
inhibition in mice lacking dopamine D2 receptors
by: Bay-Richter, C., et al.
Published: (2013) -
Dopamine D1 receptor involvement in latent inhibition and overshadowing
by: Nelson, Andrew J.D., et al.
Published: (2012)